Platinum
Showing 26 - 50 of 3,674
Intrahepatic Cholangiocarcinoma Trial (procedure, drug, biological)
Not yet recruiting
- Intrahepatic Cholangiocarcinoma
- Biopsy
- +7 more
- (no location specified)
Sep 21, 2023
CIPN and it's Impact on Quality of Life in Patients Receiving
Not yet recruiting
- Chemotherapy-induced Peripheral Neuropathy
- (no location specified)
Apr 24, 2023
Extensive-stage Small-cell Lung Cancer Trial in Pittsburgh (Durvalumab 50 MG/1 ML Intravenous Solution, Etoposide Injection,
Not yet recruiting
- Extensive-stage Small-cell Lung Cancer
- Durvalumab 50 MG/1 ML Intravenous Solution
- +4 more
-
Pittsburgh, PennsylvaniaUPMC Hillman Cancer Center
Oct 31, 2022
PARP Inhibitor Resistant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Patients Not Candidate for Platinum Retreatment
Recruiting
- PARP Inhibitor Resistant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Patients Not Candidate for Platinum Retreatment
-
Seoul, Korea, Republic ofYonsei University Health System, Severance Hospital
Dec 4, 2022
Ovarian Carcinoma Trial in New Haven (Sacituzumab govitecan)
Not yet recruiting
- Ovarian Carcinoma
- Sacituzumab govitecan
-
New Haven, ConnecticutSmilow Cancer Hospital at Yale New Haven
Aug 31, 2023
Ovarian Tumors, Ovarian Diseases Trial (Adebrelimab, Fuzuloparib)
Not yet recruiting
- Ovarian Neoplasms
- Ovarian Diseases
- (no location specified)
Feb 23, 2023
Advanced Solid Tumor, Platinum-Resistant Ovarian Cancer, Platinum-Resistant Urothelial Carcinoma Trial in Darlinghurst, Kogarah,
Terminated
- Advanced Solid Tumor
- +3 more
- NTX-301
- +2 more
-
Darlinghurst, New South Wales, Australia
- +1 more
Dec 18, 2022
Oral Squamous Cell Carcinoma Trial (Three-Week Treatment Regimen with Trastuzumab in Combination with Docetaxel and Platinum
Not yet recruiting
- Oral Squamous Cell Carcinoma
- Three-Week Treatment Regimen with Trastuzumab in Combination with Docetaxel and Platinum Triple Therapy
- (no location specified)
Nov 11, 2023
NSCLC (NSCLC) Trial (Ociperlimab, Placebo, Tislelizumab)
Not yet recruiting
- Non-small Cell Lung Cancer (NSCLC)
- Ociperlimab
- +8 more
- (no location specified)
Mar 17, 2023
Metastatic Pancreatic Carcinoma, Stage IV Pancreatic Cancer AJCC v8 Trial in Rochester (Cisplatin, Hyperthermic Intraperitoneal
Not yet recruiting
- Metastatic Pancreatic Carcinoma
- Stage IV Pancreatic Cancer AJCC v8
- Cisplatin
- +2 more
-
Rochester, MinnesotaMayo Clinic in Rochester
Jan 6, 2023
Metastatic Bone Sarcoma, Metastatic Malignant Tumor in the Lung, Metastatic Soft Tissue Sarcoma Trial in Buffalo (Cisplatin,
Recruiting
- Metastatic Bone Sarcoma
- +5 more
- Cisplatin
- +2 more
-
Buffalo, New YorkRoswell Park Cancer Institute
Jan 24, 2023
Non Small Cell Lung Cancer, Propranolol Trial (Propranolol HCl, Sintilimab, Chemotherapy)
Not yet recruiting
- Non Small Cell Lung Cancer
- Propranolol
- Propranolol hydrochloride
- +2 more
- (no location specified)
Jul 31, 2023
Small Cell Lung Cancer Trial in Nice (acetazolamide in combination with platinum and etoposide-based radiochemo)
Recruiting
- Small Cell Lung Cancer
- acetazolamide in combination with platinum and etoposide-based radiochemotherapy
-
Nice, FranceCentre Antoine Lacassagne
Jan 19, 2023
Malignant Pleural Mesothelioma Trial in Edegem, Ghent, Sint-Niklaas (Dendritic cell vaccination, Atezolizumab,
Not yet recruiting
- Malignant Pleural Mesothelioma
- Dendritic cell vaccination
- +2 more
-
Edegem, Antwerp, Belgium
- +2 more
Feb 28, 2023
Lazertinib as the 2nd-Line Treatment in EGFR Mutation+ NSCLC
Completed
- Non-small Cell Lung Cancer
- Lazertinib
- Platinum-based Chemotherapy
- (no location specified)
May 8, 2023
Metastatic Cervical Cancer Trial (Tislelizumab, Sitravatinib)
Not yet recruiting
- Metastatic Cervical Cancer
- (no location specified)
Jan 31, 2023
Cytoreductive Surgery Trial in Hangzhou (cytoreductive surgery)
Not yet recruiting
- Cytoreductive Surgery
- cytoreductive surgery
-
Hangzhou, China
- +1 more
Nov 30, 2022
Platinum-Refractory Fallopian Tube Carcinoma, Platinum-Refractory Ovarian Carcinoma, Platinum-Refractory Primary Peritoneal
Recruiting
- Platinum-Refractory Fallopian Tube Carcinoma
- +11 more
- Copanlisib Hydrochloride
- +4 more
-
Aurora, Colorado
- +2 more
Dec 8, 2022
Endometrial Cancer Trial (MK-2870, Doxorubicin, Paclitaxel)
Not yet recruiting
- Endometrial Cancer
- MK-2870
- +2 more
- (no location specified)
Nov 10, 2023
Metastatic Breast Cancer Trial in Shanghai (Vinorelbine, DDP)
Recruiting
- Metastatic Breast Cancer
-
Shanghai, ChinaFudan University Cancer Hospital
Apr 19, 2022
Untreated Advanced NSCLC Trial in Fuzhou (Recombinant human adenovirus type 5 injection (H101) combined with tirilizumab and
Recruiting
- Untreated Advanced Non-small Cell Lung Cancer
- Recombinant human adenovirus type 5 injection (H101) combined with tirilizumab and platinum-containing two-drug chemotherapy
-
Fuzhou, Fujian, ChinaFujian Cancer Hospital
Nov 13, 2023
Non Small Cell Lung Cancer, Immune Checkpoint Inhibitor, EGFR Exon 21 Mutation Trial in Peking (Pembrolizumab, pemetrexed,
Not yet recruiting
- Non Small Cell Lung Cancer
- +2 more
- Pembrolizumab, pemetrexed, platinum
- Osimertinib
-
Peking, ChinaPeking Union Medical College Hospital
Nov 16, 2023
NSCLC Stage IV Trial in Gauting (combination regimen tremelimumab /durvalumab, platinum-based chemo (SoC))
Withdrawn
- NSCLC Stage IV
- combination regimen tremelimumab /durvalumab
- platinum-based chemotherapy (SoC)
-
Gauting, GermanyAsklepios Fachkliniken München-Gauting
Sep 26, 2022
Ovarian Cancer, Malignant Tumor of Uterus Trial in New York (Sacituzumab, Cisplatin)
Not yet recruiting
- Ovarian Cancer
- Malignant Neoplasm of Uterus
-
New York, New YorkIcahn School of Medicine at Mount Sinai Division of Hematology a
Sep 14, 2023